P34 LIGHTHOUSE (OP-108): MELFLUFEN PLUS DARATUMUMAB (DARA) AND DEXAMETHASONE (DEX) VERSUS DARA IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) REFRACTORY TO AN IMMUNOMODULATORY DRUG (IMID) AND A PROTEASOME INHIBITOR (PI) OR HAD RECEIVED ≥3 PRIOR LINES OF THERAPY INCLUDING AN IMID AND A PI

• M Mateos,
• M Szarejko,
• J Bila,
• F Schjesvold,
• I Spicka,
• V Maisnar,
• A Jurczyszyn,
• Z Grudeva-Popova,
• R Hajek,
• G Usenko,
• M Thuresson,
• S Norin,
• S Jarefors,
• P Richardson,
• L Pour

Affiliations

M Mateos

1 Hospital Clínico Universitario de Salamanca/IBSAL/CIC, Salamanca, Spain

M Szarejko

2 University Clinical Centre, Department of Hematology and Transplantology, Gdansk, Poland

J Bila

3 Clinic of Hematology, Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia

F Schjesvold

4 Oslo Myeloma Center, Oslo University Hospital and KG Jebsen Center for B Cell Malignancies, University of Oslo, Oslo, Norway

I Spicka

5 1st Department of Medicine - Department of Hematology, First Faculty of Medicine, Charles University and General Hospital in Prague, Prague, Czech Republic

V Maisnar

6 4th Department of Medicine – Hematology, Charles University Hospital and Faculty of Medicine, Hradec Kralove, Czech Republic

A Jurczyszyn

7 Plasma Cell Dyscrasias Center, Department of Hematology, Jagiellonian University Faculty of Medicine, Kraków, Poland

Z Grudeva-Popova

8 Department of Clinical Oncology, Medical Faculty, Medical University of Plovdiv, Plovdiv, Bulgaria

R Hajek

9 Department of Hemato-Oncology, University Hospital Ostrava, Ostrava, Czech Republic

G Usenko

10 City Clinical Hospital No. 4 of Dnipro City Council, Dnipro, Ukraine

M Thuresson

11 Oncopeptides AB, Stockholm, Sweden

S Norin

11 Oncopeptides AB, Stockholm, Sweden

S Jarefors

11 Oncopeptides AB, Stockholm, Sweden

P Richardson

12 Dana-Farber Cancer Institute, Boston, MA, USA

L Pour

13 Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Babak Myeloma Group, Faculty of Medicine, Masaryk University, Brno, Czech Republic